✦ LIBER ✦

Comparative Effectiveness of Neoadjuvant Therapy for HER2-Positive Breast Cancer: A Network Meta-Analysis

✍ Scribed by Nagayama, A.; Hayashida, T.; Jinno, H.; Takahashi, M.; Seki, T.; Matsumoto, A.; Murata, T.; Ashrafian, H.; Athanasiou, T.; Okabayashi, K.; Kitagawa, Y.

Book ID: 127099088
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 493 KB
Volume: 106
Category: Article
ISSN: 0027-8874
DOI: 10.1093/jnci/dju203

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab combined to neoadjuvant chem

Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: A systematic review and meta-analysis

✍ Antonis Valachis; Davide Mauri; Nikolaos P. Polyzos; Grigoris Chlouverakis; Dimi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Adjuvant Trastuzumab Therapy In Her2-Pos

Adjuvant Trastuzumab Therapy In Her2-Positive Breast Cancer Patients: A Meta-Analysis Of Published Randomized Trials

✍ Xia, Y.; Bian, B.; Costea, E.; Kelton, C.M.; Guo, J.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

50 Neoadjuvant trastuzumab therapy with

50 Neoadjuvant trastuzumab therapy with or without anthracycline containing chemotherapy for HER2-positive primary breast cancer

✍ J. Horiguchi; Y. Koibuchi; N. Rokutanda; R. Nagaoka; A. Sato; H. Odawara; H. Tok 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJU

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH TRASTUZUMAB FOR HER2-POSITIVE EARLY BREAST CANCER IN POLISH SETTING

✍ E Orlewska; T Pienkowski; K Drosik; M Gyldmark; R Aultman; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

225. Effects of neoadjuvant chemotherapy

225. Effects of neoadjuvant chemotherapy for highly ER positive and HER2 negative early breast cancer patients

✍ Morimoto, T.; Nomura, T.; Takeda, M.; Shiba, I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Efficacy of neoadjuvant therapy with tra

Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer

✍ Soley Bayraktar; Ana M. Gonzalez-Angulo; Xiudong Lei; Aman U. Buzdar; Vicente Va 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 899 KB